c-Met (Cytoplasmic) Rekombinanter Antikörper
c-Met (Cytoplasmic) Rekombinant Antikörper für WB, FC (Intra), ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus, Ratte
Anwendung
WB, FC (Intra), ELISA
Konjugation
Unkonjugiert
CloneNo.
2G12
Kat-Nr. : 82904-1-RR
Synonyme
Geprüfte Anwendungen
Erfolgreiche Detektion in WB | HepG2-Zellen, HEK-293-Zellen, Mauslebergewebe, Rattenlebergewebe |
Erfolgreiche Detektion in FC (Intra) | HeLa-Zellen |
Empfohlene Verdünnung
Anwendung | Verdünnung |
---|---|
Western Blot (WB) | WB : 1:2000-1:10000 |
Durchflusszytometrie (FC) (INTRA) | FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Produktinformation
82904-1-RR bindet in WB, FC (Intra), ELISA c-Met (Cytoplasmic) und zeigt Reaktivität mit human, Maus, Ratten
Getestete Reaktivität | human, Maus, Ratte |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Rekombinant |
Typ | Antikörper |
Immunogen | c-Met (Cytoplasmic) fusion protein Ag23140 |
Vollständiger Name | met proto-oncogene (hepatocyte growth factor receptor) |
Berechnetes Molekulargewicht | 1390 aa, 155 kDa |
Beobachtetes Molekulargewicht | 140 kDa |
GenBank-Zugangsnummer | BC130420 |
Gene symbol | MET |
Gene ID (NCBI) | 4233 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein-A-Reinigung |
Lagerungspuffer | PBS with 0.02% sodium azide and 50% glycerol |
Lagerungsbedingungen | Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
c-Met (also named MET or HGFR) is a receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to the HGF ligand. c-Met regulates many physiological processes including proliferation, scattering, morphogenesis, and survival. The primary single-chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide-linked to form the mature receptor. Overexpression and/or mutation of c-Met has been reported in various human malignancies, including lung cancer, breast cancer, head and neck cancer, gastric cancer, colorectal cancer, bladder cancer, uterine cervix carcinoma, esophageal carcinoma, c-Met could serve as an important therapeutic target (PMID: 26036285). The c-met receptor is a 190-kD glycoprotein consisting of a 145-kD membrane-spanning beta chain and a 50-kD alpha chain (PMID: 7806559). In Western blot, this antibody produces bands of unknown identity at 55 and 100 kDa.
Protokolle
PRODUKTSPEZIFISCHE PROTOKOLLE | |
---|---|
WB protocol for c-Met (Cytoplasmic) antibody 82904-1-RR | Protokoll herunterladen |
FC protocol for c-Met (Cytoplasmic) antibody 82904-1-RR | Download protocol |
STANDARD-PROTOKOLLE | |
---|---|
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |